Healthcare Intelligence
Pharma - Market Access & Commercialization
Real-time intelligence, expert analysis, and verified research for the Pharma - Market Access & Commercialization industry. Stay ahead in 3 minutes a day.
Stay ahead of Pharma - Market Access & Commercialization in 3 minutes a day.
Expert-verified intelligence delivered to your inbox every morning.
Free forever. No spam. Unsubscribe anytime.
Senator Questions Merck's Keytruda Patent Strategy
Sen. Hassan presses Merck over patents that could extend Keytruda exclusivity to 2042, delaying cheaper alternatives.
Read full articleCourt Blocks Colorado's First Drug Price Cap on Enbrel
Federal judge halts 70% price cap on Amgen's Enbrel, citing federal patent law preemption and potential economic harm.
Read full articleSandoz Launches Direct-to-Consumer Platform
Sandoz debuts DTC platform offering biosimilar Omnitrope for $341/vial to cash-pay patients, bypassing traditional channels.
Read full articleIndia Simplifies Drug Launch Rules, Cuts Overcharge Liability
New rules allow drug launches without price approval for similar medicines, limit manufacturer liability for overcharging.
Read full articleColorado Drug Price Cap Ruling Threatens Other State Efforts
Judge's ruling blocking Enbrel price cap raises questions about similar laws in 10 states including NY, MD, and WA.
Read full articleSenator Questions Merck's Keytruda Patent Strategy
Sen. Hassan presses Merck over patents that could extend Keytruda exclusivity to 2042, delaying cheaper alternatives.
Read full articleCourt Blocks Colorado's First Drug Price Cap on Enbrel
Federal judge halts 70% price cap on Amgen's Enbrel, citing federal patent law preemption and potential economic harm.
Read full articleSandoz Launches Direct-to-Consumer Platform
Sandoz debuts DTC platform offering biosimilar Omnitrope for $341/vial to cash-pay patients, bypassing traditional channels.
Read full articleIndia Simplifies Drug Launch Rules, Cuts Overcharge Liability
New rules allow drug launches without price approval for similar medicines, limit manufacturer liability for overcharging.
Read full articleColorado Drug Price Cap Ruling Threatens Other State Efforts
Judge's ruling blocking Enbrel price cap raises questions about similar laws in 10 states including NY, MD, and WA.
Read full articleStay ahead of Pharma - Market Access & Commercialization in 3 minutes a day.
Live opportunity intelligence for your market, delivered to your inbox every morning. Read it over coffee.
Free forever. No spam. Unsubscribe anytime.